Sugi Predict

Sugi Predict / Compounds / SCHEMBL841673

SCHEMBL841673

SCHEMBL841673

NS(=O)(=O)c1ccc(Br)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 14/20 0.51
▸ CA1 P00915 12/20 0.51
▸ CA9 Q16790 10/20 0.51
▸ CA7 P43166 5/20 0.51
▸ CA14 Q9ULX7 5/20 0.51
▸ CA12 O43570 8/20 0.48
▸ CA4 P22748 5/20 0.48
▸ CA6 P23280 5/20 0.48
▸ CA5A P35218 4/20 0.48
▸ CA5B Q9Y2D0 4/20 0.48
▸ CA3 P07451 3/20 0.48
▸ ALOX5 P09917 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ HSD11B1 P28845 1/20 0.44
▸ CA13 Q8N1Q1 3/20 0.43
▸ CISD1 Q9NZ45 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ APEX1 P27695 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3533549 0.98 CA2 (0.50) CA2CA1CA9CA7CA14
SCHEMBL2240806 0.83 CA2 (0.48) CA2CA1CA9CA7CA14
SCHEMBL29209807 0.81 HSD11B1 (0.45) CA2CA1CA9CA7CA14
SCHEMBL16507 0.81 TRPV4 (0.53) CA2CA1CA9CA7CA14
SCHEMBL29430629 0.79 HSD11B1 (0.48) CA2CA1CA9CA7CA14
SCHEMBL2188372 0.79 CA12 (0.48) CA2CA1CA9CA7CA14
SCHEMBL11650766 0.79 HSD11B1 (0.48) CA2CA1CA9CA7CA14
SCHEMBL1581780 0.79 HSD11B1 (0.48) CA2CA1CA9CA7CA14
SCHEMBL29587590 0.78 CA1 (0.53) CA2CA1CA9CA7CA14
SCHEMBL962913 0.78 CA1 (0.53) CA2CA1CA9CA7CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108963389-B Gelable system for lithium-air battery and preparation method and application thereof 北京师范大学 2020-11-13 — — CN claimed
EP-3637524-A1 GELATINIZED SYSTEM AND APPLICATIONS IN LITHIUM AIR BATTERY, SUPER CAPACITOR OR CAPACITOR BATTERY IN ORGANIC SYSTEM Beijing Normal University (CN) 2020-04-15 — — EP claimed
EP-3637525-A1 FLEXIBLE ALL-SOLID-STATE LITHIUM-ION SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR Beijing Normal University (CN) 2020-04-15 — — EP claimed
US-20200099090-A1 FLEXIBLE ALL-SOLID-STATE LITHIUM-ION SECONDARY BATTERY AND PREPARATION METHOD THEREOF BEIJING NORMAL UNIVERSITY (CN) 2020-03-26 — — US claimed
US-20200099097-A1 GELABLE SYSTEM AND USES THEREOF IN LITHIUM-AIR BATTERIES, ORGANIC SUPERCAPACITORS OR CAPACITOR BATTERIES BEIJING NORMAL UNIVERSITY (CN) 2020-03-26 — — US claimed
US-11557793-B2 Flexible all-solid-state lithium-ion secondary battery having gelable system containing lithium salt and ether compound, and preparation method thereof BEIJING NORMAL UNIVERSITY (CN) 2023-01-17 — — US disclosed
US-11545696-B2 Gelable system and uses thereof in lithium-air batteries, organic supercapacitors or capacitor batteries BEIJING NORMAL UNIVERSITY (CN) 2023-01-03 — — US disclosed
US-20220267276-A1 NLRP MODULATORS NOVARTIS INFLAMMASOME RESEARCH, INC. 2022-08-25 — — US disclosed
US-20210395241-A1 NLRP MODULATORS NOVARTIS INFLAMMASOME RESEARCH, INC. 2021-12-23 — — US disclosed
CN-113613721-A NLRP modulators 诺华股份有限公司 2021-11-05 — — CN disclosed
EP-3817815-A1 NLRP MODULATORS Novartis AG (CH) 2021-05-12 — — EP disclosed
EP-3817817-A1 NLRP MODULATORS Novartis AG (CH) 2021-05-12 — — EP disclosed
US-20080051441-A1 Aryl Sulphonamide Modulators ASTRAZENECA AB (SE) 2008-02-28 — — US disclosed
US-20080051441-A1 Aryl Sulphonamide Modulators ASTRAZENECA AB (SE) 2008-02-28 — — US disclosed
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 — — US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 — — EP disclosed
WO-2007026104-A1 PYRROLOPYRIDINE DERIVATIVES AND USE OF SAME AS PPAR RECEPTOR MODULATORS LABORATOIRES FOURNIER S.A. (FR) 2007-03-08 — — WO disclosed
US-20060111353-A1 Substituted arylcyclopropylacetamides as glucokinase activators ELI LILLY AND COMPANY 2006-05-25 — — US disclosed
EP-1585739-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2005-10-19 — — EP disclosed
WO-2004063179-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2004-07-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395241-A1 NLRP MODULATORS NLRP1, NLRP3, NOD1 CA2 1928/4885CA1 4414/4885CA9 4068/4885
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 CA2 236/4885CA1 1466/4885CA9 1446/4885
US-20060111353-A1 Substituted arylcyclopropylacetamides as glucokinase activators GCK, GCKR, GALK1 CA2 1004/4885CA1 3133/4885CA9 1788/4885
US-20220267276-A1 NLRP MODULATORS NLRP1, NRP1, NR4A3 CA2 2463/4885CA1 4067/4885CA9 4279/4885
US-20080051441-A1 Aryl Sulphonamide Modulators CHRM2, CHRM1, CHRNA1 CA2 3701/4885CA1 4197/4885CA9 4418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.